CA2120745A1 - A combination of anti-erbb-2 monoclonal antibodies and method of using - Google Patents

A combination of anti-erbb-2 monoclonal antibodies and method of using

Info

Publication number
CA2120745A1
CA2120745A1 CA 2120745 CA2120745A CA2120745A1 CA 2120745 A1 CA2120745 A1 CA 2120745A1 CA 2120745 CA2120745 CA 2120745 CA 2120745 A CA2120745 A CA 2120745A CA 2120745 A1 CA2120745 A1 CA 2120745A1
Authority
CA
Canada
Prior art keywords
antibodies
ab
antibody
combination
erbb
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2120745
Other languages
French (fr)
Inventor
Philip G. Kasprzyk
Charles R. King
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ONCOLOGIX Inc
Original Assignee
Philip G. Kasprzyk
Charles R. King
Oncologix, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US90655592A priority Critical
Priority to US07/906,555 priority
Application filed by Philip G. Kasprzyk, Charles R. King, Oncologix, Inc. filed Critical Philip G. Kasprzyk
Publication of CA2120745A1 publication Critical patent/CA2120745A1/en
Application status is Abandoned legal-status Critical

Links